The Minnesota Timberwolves will be one of the first teams to participate in the Mayo Clinic's antibody study.

The research study is centered around studying the antibodies of people who have recovered from COVID-19 in hopes of potentially finding a vaccine. 

The Blazers are also participating in the research study. 

Several league figures who have recovered from the virus have donated their plasma for medical research.